- Cardinal Health, headquartered in Dublin, Ohio, is a leading wholesaler in the healthcare sector, specializing in the distribution of pharmaceuticals and medical products, with a strong focus on specialty medicines and advanced therapies.
- In April 2026, Cardinal Health expanded its Actinium-225 production capacity at its Center for Theranostics Advancement in Indianapolis to meet the growing demand for novel cancer therapies, supporting over 15 clinical trials.
- The company has recently introduced the ContinuCare™ Pathway program to enhance diabetes supply management, partnering with Publix Super Markets Inc. to streamline patient care in community settings.
- With a projected 16% compounded annual growth rate in Specialty revenues expected to exceed $50 billion in fiscal 2026, Cardinal Health's ideal buyers are healthcare providers seeking innovative solutions for advanced therapies, making it a critical time for sales teams to engage with the company.
Cardinal Health's workforce is organized into 19 departments, with a significant concentration in Operations, which employs 3,364 individuals. Information Technology and Sales follow, with headcounts of 1,337 and 941, respectively. The balance across departments reflects a strong operational focus, complemented by robust support functions in IT and Sales, which are critical for the company's growth and service delivery.
The company's workforce is distributed across 894 locations, with the highest concentration in Dublin, OH, housing 2,925 employees. Columbus, OH, and La Vergne, TN, also contribute significantly, with 600 and 145 employees, respectively. The large 'Other' category, comprising 5,663 employees, indicates a widespread geographic presence, suggesting a decentralized operational model that supports diverse market needs.
